Immunohistochemistry on IDH 1/2, ATRX, p53 and Ki-67 substitute molecular genetic testing and predict patient prognosis in grade III adult diffuse gliomas-Reference-Cited by-同舟云学术

Immunohistochemistry on IDH 1/2, ATRX, p53 and Ki-67 substitute molecular genetic testing and predict patient prognosis in grade III adult diffuse gliomas

Published:2016-03-11 Issue:2 Volume:33 Page:107-116
ISSN:1433-7398
Container-title:Brain Tumor Pathology
language:en
Short-container-title:Brain Tumor Pathol

Author:

Takano Shingo,Ishikawa Eiichi,Sakamoto Noriaki,Matsuda Masahide,Akutsu Hiroyoshi,Noguchi Masayuki,Kato Yukinari,Yamamoto Tetsuya,Matsumura Akira

Funder

Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan

Japan Brain Foundation

japanese Foundation for Multidiciplinary Treatment of Cancer

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10014-016-0260-x.pdf

Reference32 articles.

1. Reuss DE, Sahm F, Schrimpf D, Wiestler B, Capper D, Koelsche C, Schweizer L, Korshunov A, Jones DT, Hovestadt V, Mittelbronn M, Schittenhelm J, Herold-Mende C, Unterberg A, Platten M, Weller M, Wick W, Pfister SM, von Deimling A (2015) ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an “integrated” diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma. Acta Neuropathol 129:133–146

2. Weller M, Weber RG, Willscher E, Riehmer V, Hentschel B, Kreuz M, Felsberg J, Beyer U, Löffler-Wirth H, Kaulich K, Steinbach JP, Hartmann C, Gramatzki D, Schramm J, Westphal M, Schackert G, Simon M, Martens T, Boström J, Hagel C, Sabel M, Krex D, Tonn JC, Wick W, Noell S, Schlegel U, Radlwimmer B, Pietsch T, Loeffler M, von Deimling A, Binder H, Reifenberger G (2015) Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups. Acta Neuropathol 129:679–693

3. Louis DN, Perry A, Burger P, Ellison DW, Reifenberger G, von Deimling A, Aldape K, Brat D, Collins VP, Eberhart C, Figarella-Branger D, Fuller GN, Giangaspero F, Giannini C, Hawkins C, Kleihues P, Korshunov A, Kros JM, Beatriz Lopes M, Ng HK, Ohgaki H, Paulus W, Pietsch T, Rosenblum M, Rushing E, Soylemezoglu F, Wiestler O, Wesseling P (2014) International Society Of Neuropathology-Haarlem. International Society Of Neuropathology-Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol 24:429–435

4. Ceccarelli M, Barthel FP, Malta TM et al (2016) Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma. Cell 164:550–563

5. Tanboon J, Williams EA, Louis DN (2015) The Diagnostic use of immunohistochemical surrogates for signature molecular genetic alterations in gliomas. J Neuropathol Exp Neurol 75:4–18. doi: 10.1093/jnen/nlv009

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and Antitumour Evaluation of Tricyclic Indole‐2‐Carboxamides against Paediatric Brain Cancer Cells;ChemMedChem;2024-08-08

2. A Synopsis of Biomarkers in Glioblastoma: Past and Present;Current Issues in Molecular Biology;2024-07-03

3. Evaluation of Microvascular Density in Glioblastomas in Relation to p53 and Ki67 Immunoexpression;International Journal of Molecular Sciences;2024-06-20

4. Per- and polyfluoroalkyl substances (PFAS) exposure in plasma and their blood–brain barrier transmission efficiency–A pilot study;Environment International;2024-05

5. Expression of molecular markers and synergistic anticancer effects of chemotherapy with antimicrobial peptides on glioblastoma cells;Cancer Chemotherapy and Pharmacology;2024-01-27